teva ni limited
teva ni limited Company Information
Company Number
NI023272
Next Accounts
Sep 2025
Shareholders
teva milbrook holdings limited
Group Structure
View All
Industry
Manufacture of pharmaceutical preparations
Registered Address
old belfast road millbrook, larne, northern ireland, BT40 2SH
Website
http://wcrx.comteva ni limited Estimated Valuation
Pomanda estimates the enterprise value of TEVA NI LIMITED at £10.5m based on a Turnover of £11.4m and 0.92x industry multiple (adjusted for size and gross margin).
teva ni limited Estimated Valuation
Pomanda estimates the enterprise value of TEVA NI LIMITED at £11.8m based on an EBITDA of £2.9m and a 4x industry multiple (adjusted for size and gross margin).
teva ni limited Estimated Valuation
Pomanda estimates the enterprise value of TEVA NI LIMITED at £200.1m based on Net Assets of £102.5m and 1.95x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Teva Ni Limited Overview
Teva Ni Limited is a live company located in northern ireland, BT40 2SH with a Companies House number of NI023272. It operates in the manufacture of pharmaceutical preparations sector, SIC Code 21200. Founded in November 1989, it's largest shareholder is teva milbrook holdings limited with a 100% stake. Teva Ni Limited is a mature, mid sized company, Pomanda has estimated its turnover at £11.4m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Teva Ni Limited Health Check
Pomanda's financial health check has awarded Teva Ni Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 4 areas for improvement. Company Health Check FAQs
3 Strong
2 Regular
4 Weak
Size
annual sales of £11.4m, make it smaller than the average company (£35m)
£11.4m - Teva Ni Limited
£35m - Industry AVG
Growth
3 year (CAGR) sales growth of -2%, show it is growing at a slower rate (4.5%)
-2% - Teva Ni Limited
4.5% - Industry AVG
Production
with a gross margin of 6%, this company has a higher cost of product (32.9%)
6% - Teva Ni Limited
32.9% - Industry AVG
Profitability
an operating margin of 18.7% make it more profitable than the average company (8.9%)
18.7% - Teva Ni Limited
8.9% - Industry AVG
Employees
with 93 employees, this is similar to the industry average (102)
93 - Teva Ni Limited
102 - Industry AVG
Pay Structure
on an average salary of £60.9k, the company has an equivalent pay structure (£70.6k)
£60.9k - Teva Ni Limited
£70.6k - Industry AVG
Efficiency
resulting in sales per employee of £122.4k, this is less efficient (£382.3k)
£122.4k - Teva Ni Limited
£382.3k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Teva Ni Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 68 days, this is slower than average (34 days)
68 days - Teva Ni Limited
34 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Teva Ni Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Teva Ni Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 5.3%, this is a lower level of debt than the average (44.4%)
5.3% - Teva Ni Limited
44.4% - Industry AVG
TEVA NI LIMITED financials
Teva Ni Limited's latest turnover from December 2023 is £11.4 million and the company has net assets of £102.5 million. According to their latest financial statements, Teva Ni Limited has 93 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 11,384,000 | 12,179,000 | 15,405,740 | 12,082,308 | 11,844,961 | 12,789,116 | 14,178,049 | 19,509,848 | 18,953,645 | 50,977,401 | 65,577,659 | 60,798,387 | 61,311,439 | 64,987,001 | 14,779,728 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 10,705,000 | 11,579,000 | 10,608,464 | 10,553,907 | 9,999,324 | 10,821,037 | 12,496,722 | 16,864,280 | 15,240,794 | 42,828,614 | 51,764,445 | 47,083,940 | 47,562,519 | 49,050,345 | 12,807,751 |
| Gross Profit | 679,000 | 600,000 | 4,797,276 | 1,528,401 | 1,845,637 | 1,968,079 | 1,681,327 | 2,645,568 | 3,712,851 | 8,148,787 | 13,813,214 | 13,714,447 | 13,748,920 | 15,936,656 | 1,971,977 |
| Admin Expenses | -1,444,000 | -1,129,000 | 23,092 | 749,826 | 994,602 | 1,152,794 | 329,594 | -3,202,351 | 457,288 | 6,031,530 | 11,296,123 | 11,227,311 | 10,364,429 | 10,712,703 | 460,610 |
| Operating Profit | 2,123,000 | 1,729,000 | 4,774,184 | 778,575 | 851,035 | 815,285 | 1,351,733 | 5,847,919 | 3,255,563 | 2,117,257 | 2,517,091 | 2,487,136 | 3,384,491 | 5,223,953 | 1,511,367 |
| Interest Payable | 33,000 | 29,000 | 81,629 | 173,410 | 216,828 | 8,556 | 5,359 | ||||||||
| Interest Receivable | 4,835,000 | 2,372,000 | 1,226,266 | 1,188,099 | 1,205,516 | 515,104 | 32,115 | 35,805 | 33,993 | 11,884 | 83,544 | 178 | 5,114 | ||
| Pre-Tax Profit | 6,925,000 | 4,072,000 | 6,000,450 | 1,966,674 | 5,764,969 | 1,621,842 | 1,383,848 | 5,883,724 | 3,289,556 | 2,129,141 | 2,435,462 | 2,313,726 | 3,251,207 | 5,215,575 | 1,511,122 |
| Tax | -1,757,000 | -943,000 | -1,450,313 | -551,632 | -1,143,791 | -436,946 | -258,943 | -1,454,746 | -960,846 | 472,697 | -125,719 | 21,458 | -449,148 | -1,306,839 | -276,644 |
| Profit After Tax | 5,168,000 | 3,129,000 | 4,550,137 | 1,415,042 | 4,621,178 | 1,184,896 | 1,124,905 | 4,428,978 | 2,328,710 | 2,601,838 | 2,309,743 | 2,335,184 | 2,802,059 | 3,908,736 | 1,234,478 |
| Dividends Paid | |||||||||||||||
| Retained Profit | 5,168,000 | 3,129,000 | 4,550,137 | 1,415,042 | 4,621,178 | 1,184,896 | 1,124,905 | 4,428,978 | 2,328,710 | 2,601,838 | 2,309,743 | 2,335,184 | 2,802,059 | 3,908,736 | 1,234,478 |
| Employee Costs | 5,661,000 | 5,171,000 | 5,221,121 | 5,009,154 | 4,823,112 | 6,188,395 | 6,529,560 | 8,165,586 | 9,016,450 | 10,082,902 | 15,036,175 | 10,767,874 | 11,124,539 | 7,997,542 | 4,241,239 |
| Number Of Employees | 93 | 91 | 93 | 89 | 95 | 126 | 144 | 144 | 150 | 201 | 225 | 211 | 214 | 182 | 120 |
| EBITDA* | 2,945,000 | 2,523,000 | 5,660,741 | 1,786,846 | 1,872,305 | 1,947,728 | 2,471,203 | 7,127,376 | 4,562,232 | 3,445,194 | 4,139,405 | 4,589,709 | 5,873,509 | 7,312,833 | 2,584,921 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 8,690,000 | 9,028,000 | 8,731,334 | 9,262,935 | 10,034,364 | 10,985,806 | 11,826,042 | 12,684,868 | 14,569,680 | 14,239,238 | 14,098,404 | 14,465,973 | 15,142,742 | 15,096,211 | 13,925,692 |
| Intangible Assets | 123,113 | 492,455 | 861,797 | ||||||||||||
| Investments & Other | 9,992,741 | 9,992,741 | 29,372,459 | 29,372,459 | 29,372,459 | 29,372,459 | 29,372,459 | 29,372,459 | 30,480,484 | ||||||
| Debtors (Due After 1 year) | 620,000 | 1,111,441 | 1,651,437 | 1,715,658 | |||||||||||
| Total Fixed Assets | 8,690,000 | 9,648,000 | 9,842,775 | 10,914,372 | 11,750,022 | 10,985,806 | 21,818,783 | 22,677,609 | 43,942,139 | 43,611,697 | 43,470,863 | 43,961,545 | 45,007,656 | 45,330,467 | 44,406,176 |
| Stock & work in progress | 13,521 | 18,337 | 8,362 | 643,933 | 577,858 | 908,406 | 527,271 | 1,042,327 | 12,022,197 | 4,618,600 | 4,562,246 | 9,207,745 | 1,374,476 | ||
| Trade Debtors | 90,017,116 | 83,191,346 | 3,918 | 7,815,923 | 8,530,523 | 8,610,596 | 13,487,833 | ||||||||
| Group Debtors | 97,738,000 | 91,922,000 | 78,841,326 | 73,595,622 | 72,925,120 | 70,804,720 | 44,906,475 | 44,761,524 | 33,810,184 | 31,102,840 | 9,762,155 | 12,218,591 | 3,049,925 | ||
| Misc Debtors | 1,771,000 | 1,550,000 | 969,873 | 1,417,798 | 2,322,424 | 956,369 | 2,480,943 | 2,613,156 | 1,636,555 | 2,538,497 | 423,850 | 684,930 | 1,109,537 | ||
| Cash | 51,000 | 109,000 | 123,409 | 122,698 | 115,345 | 216,849 | 291,815 | 183,325 | 146,749 | 1,055,671 | 5,748,746 | 12,346,125 | 11,627,484 | 1,033,875 | |
| misc current assets | |||||||||||||||
| total current assets | 99,509,000 | 93,523,000 | 90,139,637 | 83,333,092 | 79,942,259 | 75,772,698 | 76,042,251 | 72,961,310 | 48,098,014 | 48,567,674 | 56,340,530 | 52,539,206 | 35,704,972 | 47,226,583 | 6,567,813 |
| total assets | 108,199,000 | 103,171,000 | 99,982,412 | 94,247,464 | 91,692,281 | 86,758,504 | 97,861,034 | 95,638,919 | 92,040,153 | 92,179,371 | 99,811,393 | 96,500,751 | 80,712,628 | 92,557,050 | 50,973,989 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 2,004,000 | 1,506,000 | 5,119,569 | 4,268,147 | 433,584 | 433,186 | 504,489 | 314,156 | 817,912 | 413,189 | 2,309,315 | 2,463,722 | 2,355,203 | 1,324,720 | 445,674 |
| Group/Directors Accounts | 421,000 | 195,000 | 98,360 | 379,140 | 12,285,268 | 10,829,439 | 10,823,065 | 12,273,962 | 12,599,506 | 13,290,138 | 12,028,589 | 24,402,063 | |||
| other short term finances | |||||||||||||||
| hp & lease commitments | 92,000 | 86,000 | |||||||||||||
| other current liabilities | 1,875,000 | 2,922,000 | 2,725,559 | 2,222,743 | 2,109,712 | 2,842,667 | 3,186,666 | 5,060,590 | 7,258,358 | 7,457,797 | 4,927,364 | 8,970,906 | 2,999,586 | ||
| total current liabilities | 4,392,000 | 4,709,000 | 5,119,569 | 4,268,147 | 3,257,503 | 3,035,069 | 14,899,469 | 13,986,262 | 14,827,643 | 17,747,741 | 22,167,179 | 23,211,657 | 19,311,156 | 34,697,689 | 3,445,260 |
| loans | |||||||||||||||
| hp & lease commitments | 256,000 | 348,000 | |||||||||||||
| Accruals and Deferred Income | 5,985,243 | 5,985,243 | 5,985,243 | 5,985,243 | |||||||||||
| other liabilities | |||||||||||||||
| provisions | 1,097,000 | 920,000 | 886,513 | 672,812 | 639,897 | 699,131 | 726,963 | 713,154 | 744,684 | 593,147 | 511,330 | 646,051 | 421,311 | 482,891 | 618,567 |
| total long term liabilities | 1,353,000 | 1,268,000 | 886,513 | 672,812 | 639,897 | 699,131 | 726,963 | 713,154 | 744,684 | 593,147 | 6,496,573 | 6,631,294 | 6,406,554 | 6,468,134 | 618,567 |
| total liabilities | 5,745,000 | 5,977,000 | 6,006,082 | 4,940,959 | 3,897,400 | 3,734,200 | 15,626,432 | 14,699,416 | 15,572,327 | 18,340,888 | 28,663,752 | 29,842,951 | 25,717,710 | 41,165,823 | 4,063,827 |
| net assets | 102,454,000 | 97,194,000 | 93,976,330 | 89,306,505 | 87,794,881 | 83,024,304 | 82,234,602 | 80,939,503 | 76,467,826 | 73,838,483 | 71,147,641 | 66,657,800 | 54,994,918 | 51,391,227 | 46,910,162 |
| total shareholders funds | 102,454,000 | 97,194,000 | 93,976,330 | 89,306,505 | 87,794,881 | 83,024,304 | 82,234,602 | 80,939,503 | 76,467,826 | 73,838,483 | 71,147,641 | 66,657,800 | 54,994,918 | 51,391,227 | 46,910,162 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 2,123,000 | 1,729,000 | 4,774,184 | 778,575 | 851,035 | 815,285 | 1,351,733 | 5,847,919 | 3,255,563 | 2,117,257 | 2,517,091 | 2,487,136 | 3,384,491 | 5,223,953 | 1,511,367 |
| Depreciation | 822,000 | 794,000 | 886,557 | 1,008,271 | 1,021,270 | 1,132,443 | 1,119,470 | 1,279,457 | 1,306,669 | 1,327,937 | 1,499,201 | 1,733,231 | 2,119,676 | 1,842,652 | 1,073,554 |
| Amortisation | 123,113 | 369,342 | 369,342 | 246,228 | |||||||||||
| Tax | -1,757,000 | -943,000 | -1,450,313 | -551,632 | -1,143,791 | -436,946 | -258,943 | -1,454,746 | -960,846 | 472,697 | -125,719 | 21,458 | -449,148 | -1,306,839 | -276,644 |
| Stock | -13,521 | -4,816 | 9,975 | -635,571 | 66,075 | -330,548 | 381,135 | -515,056 | -10,979,870 | 7,403,597 | 56,354 | -4,645,499 | 7,833,269 | 1,374,476 | |
| Debtors | 5,417,000 | 2,963,443 | 6,285,774 | 3,315,926 | 6,513,437 | -234,124 | 3,486,455 | 24,373,671 | 8,820 | 4,115,936 | 1,090,802 | 23,375,259 | -7,594,753 | 22,231,892 | 4,159,462 |
| Creditors | 498,000 | -3,613,569 | 851,422 | 3,834,563 | 398 | -71,303 | 190,333 | -503,756 | 404,723 | -1,896,126 | -154,407 | 108,519 | 1,030,483 | 879,046 | 445,674 |
| Accruals and Deferred Income | -1,047,000 | 2,922,000 | -2,725,559 | 502,816 | 113,031 | -732,955 | -343,999 | -1,873,924 | -8,183,011 | -199,439 | 2,530,433 | -4,043,542 | 11,956,563 | 2,999,586 | |
| Deferred Taxes & Provisions | 177,000 | 33,487 | 213,701 | 32,915 | -59,234 | -27,832 | 13,809 | -31,530 | 151,537 | 81,817 | -134,721 | 224,740 | -61,580 | -135,676 | 618,567 |
| Cash flow from operations | -4,601,000 | -2,028,004 | -1,005,407 | -948,768 | -4,705,372 | 1,692,727 | -1,472,460 | -19,961,461 | 2,789,958 | 784,505 | -4,969,280 | -15,956,754 | 14,589,974 | -11,359,234 | 838,166 |
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | -9,992,741 | -19,379,718 | -1,108,025 | 30,480,484 | |||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | 226,000 | 195,000 | -98,360 | -280,780 | -11,906,128 | 1,455,829 | 6,374 | -1,450,897 | -325,544 | -690,632 | 1,261,549 | -12,373,474 | 24,402,063 | ||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | -86,000 | 434,000 | |||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | 4,802,000 | 2,343,000 | 1,226,266 | 1,188,099 | 1,205,516 | 515,104 | 32,115 | 35,805 | 33,993 | 11,884 | -81,629 | -173,410 | -133,284 | -8,378 | -245 |
| cash flow from financing | 5,034,000 | 3,060,670 | 1,345,954 | 1,186,321 | 1,074,135 | -11,786,218 | 1,658,138 | 84,878 | -1,116,271 | -224,656 | 1,407,837 | 10,415,837 | -11,705,126 | 24,966,014 | 45,675,439 |
| cash and cash equivalents | |||||||||||||||
| cash | -51,000 | -58,000 | -14,409 | 711 | 7,353 | -101,504 | -74,966 | 108,490 | 36,576 | -908,922 | -4,693,075 | -6,597,379 | 718,641 | 10,593,609 | 1,033,875 |
| overdraft | |||||||||||||||
| change in cash | -51,000 | -58,000 | -14,409 | 711 | 7,353 | -101,504 | -74,966 | 108,490 | 36,576 | -908,922 | -4,693,075 | -6,597,379 | 718,641 | 10,593,609 | 1,033,875 |
teva ni limited Credit Report and Business Information
Teva Ni Limited Competitor Analysis
Perform a competitor analysis for teva ni limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mid companies, companies in BT40 area or any other competitors across 12 key performance metrics.
teva ni limited Ownership
TEVA NI LIMITED group structure
Teva Ni Limited has 1 subsidiary company.
Ultimate parent company
TEVA PHARMACEUTICAL INDUSTRIES LTD
#0018335
2 parents
TEVA NI LIMITED
NI023272
1 subsidiary
teva ni limited directors
Teva Ni Limited currently has 2 directors. The longest serving directors include Mr Brendan Muldoon (Apr 2016) and Mr Dean Cooper (Jul 2021).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Brendan Muldoon | Northern Ireland | 48 years | Apr 2016 | - | Director |
| Mr Dean Cooper | United Kingdom | 52 years | Jul 2021 | - | Director |
P&L
December 2023turnover
11.4m
-7%
operating profit
2.1m
+23%
gross margin
6%
+21.07%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
102.5m
+0.05%
total assets
108.2m
+0.05%
cash
0
-1%
net assets
Total assets minus all liabilities
teva ni limited company details
company number
NI023272
Type
Private limited with Share Capital
industry
21200 - Manufacture of pharmaceutical preparations
incorporation date
November 1989
age
36
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
warner chilcott uk limited (May 2018)
rouvex limited (June 2004)
accountant
-
auditor
PRICEWATERHOUSECOOPERS LLP
address
old belfast road millbrook, larne, northern ireland, BT40 2SH
Bank
CITIBANK
Legal Advisor
-
teva ni limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 8 charges/mortgages relating to teva ni limited. Currently there are 0 open charges and 8 have been satisfied in the past.
teva ni limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for TEVA NI LIMITED. This can take several minutes, an email will notify you when this has completed.
teva ni limited Companies House Filings - See Documents
| date | description | view/download |
|---|
